COVID-19 Fuels Demand for Citrus Bioflavonoid Supplements for Effective Immunoregulation
Companies in the citrus bioflavonoids market are capitalizing on value-grab opportunities, due to the ongoing COVID-19 (coronavirus) pandemic, since these health agents help in immunoregulation. Wuhan being the epicenter of the virus reported increasing number of pneumonia cases, which stirred a demand for citrus fruits rich in flavonoids. Thus, citrus bioflavonoid supplements are emerging as a novel candidate to reduce the severity of COVID-19 symptoms.
An unprecedented demand for antiviral agents bolstered the credibility of companies in the citrus bioflavonoids market. Health-promoting benefits of flavonoids such as cough relief and regulation of digestive health are helping to increase patient outcomes. Likewise, increased clinical trials validate the importance of hesperidin that acts as an inhibitor to the COVID-19 strain. Hence, manufacturers are increasing their production capabilities to induce hesperidin and naringin in nutraceuticals.
Request A Sample-https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=59439
Citrus Bioflavonoid Ingredients Instrumental in Reducing Insulin Resistance
Citrus bioflavonoids hold promising potentials in managing blood sugar levels. Companies in the citrus bioflavonoids market are gaining proficiency in clinical trials to innovate in new bioflavonoid complexes that help to control blood pressure, sugar levels, and inflammation. They are increasing efforts to combine the efficacy of eriocitrin with other bioactives such as naringin and hesperidin to minimize health issues of pre-diabetes and inflammation patients. An alarmingly high prevalence of pre-diabetes patients worldwide is a key driver, which is boosting the growth for the citrus bioflavonoids market, where the market is estimated to reach a value of ~US$ 2 Bn by the end of 2030.
Companies are participating in trade events to launch their products and gain visibility among target customers. They are teaming up with international medical laboratories to validate their clinical trials about citrus bioflavonoid ingredients. Randomized study on prediabetics is helping companies to gain insights on how bioflavonoids help to reduce insulin resistance and systolic blood pressure.
REQUEST FOR COVID19 IMPACT ANALYSIS –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59439
Glucosyl-hesperidin holds Promising Potentials in Renal Disease Management
Health benefits of citrus bioflavonoids are being highly publicized in the market landscape. Researchers in Japan claim to find a promising citrus bioflavonoid that can help reduce the progression of kidney disease. For instance, Thanutchaporn Kumrungsee — an assistant professor of the molecular nutrition laboratory at the Hiroshima University states that novel citrus bioflavonoid complexes hold growth potentials in the field of functional foods.
Since chronic kidney disease (CKD) affects millions of people every year, ingredient companies in the citrus bioflavonoids market are focusing on functional food to prevent the progression of CKD in patients. Since most CKD cases require dialysis or kidney transplantation in end stage diagnosis, healthcare practitioners are now recommending the consumption of bioflavonoid supplements to reduce the severity of renal diseases. Companies in the citrus bioflavonoids market are taking cues from mouse models that show a decrease in inflammation within the kidneys with the assistance of glucosyl-hesperidin (G-Hes).
e-Commerce Generates Revenue Streams for Companies Focusing on Transparency in Product Reviews
The citrus bioflavonoids market is estimated to expand at a CAGR of 6.2% during the forecast period. Bioflavonoids are gaining increased visibility in dietary supplements and pharmaceutical products. However, not all uses of citrus bioflavonoids are approved by the U.S. FDA (Food and Drug Association). This poses as a challenge to introduce new product offerings in nutraceuticals and pharmaceuticals for companies in the citrus bioflavonoids market. Hence, companies are educating customers to read the labels of products before consumption and to seek medical prescription from doctors to avoid any side effects on products.
On the other hand, companies are tapping into incremental opportunities via e-Commerce to generate revenue streams. For instance, Purayati is an emerging Indian brand dealing in multivitamins and supplements, and is aggressive on marketing its vitamin C tablets induced with citrus bioflavonoids that act as effective antioxidants. The transparency in product reviews is bolstering the credibility of manufacturers and increasing product uptake. Manufacturers are adopting ISO (International Organization for Standardization)-certified manufacturing plants to meet requirements of pro-health customers.
